Correction
for Metso et al.,
J Clin Endocrinol Metab
92 (6) 2190-2196.
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 10 4008
Copyright © 2007 by The Endocrine Society
Announcement and Resource |
Erratum
In the article "Increased Cardiovascular and Cancer Mortality after Radioiodine Treatment for Hyperthyroidism" by Saara Metso, Pia Jaatinen, Heini Huhtala, Anssi Auvinen, Heikki Oksala, and Jorma Salmi (The Journal of Clinical Endocrinology & Metabolism 92:2190–2196), the authors wish to run the following note.
The authors apologize for failing to cite reciprocally two recently published studies concerning long-term consequences after treatment of hyperthyroidism with radioactive iodine (RAI). In the first paper (Increased cancer incidence after radioiodine treatment for hyperthyroidism Cancer 2007 May 15; 109(10):1972–1979), we reported increased cancer incidence in patients treated with RAI compared with the age- and gender-matched controls; observed incidences of stomach, kidney, and breast cancer were increased among RAI-treated patients. In the second paper (Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism J Clin Endocrinol Metab 2007 Jun; 92(6):2190–2196), we reported increased total mortality in these cohorts; this was largely explained by cerebrovascular disease, although increased mortality from all cancers and gastro-esophageal cancer was also reported. These data were complementary to each other, with one years difference in the follow-up period.
The authors regret the error.